MedPath

Lovastatin

Lovastatin Tablet USP Revision I

Approved
Approval ID

4444573e-9df1-01e6-e054-00144ff8d46c

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Jan 11, 2021

Manufacturers
FDA

NuCare Pharmaceuticals, Inc.

DUNS: 010632300

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Lovastatin

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code66267-561
Application NumberANDA075991
Product Classification
M
Marketing Category
C73584
G
Generic Name
Lovastatin
Product Specifications
Route of AdministrationORAL
Effective DateJanuary 11, 2021
FDA Product Classification

INGREDIENTS (9)

CELLULOSE, MICROCRYSTALLINEInactive
Code: OP1R32D61U
Classification: IACT
LACTOSE MONOHYDRATEInactive
Code: EWQ57Q8I5X
Classification: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30
Classification: IACT
POLOXAMER 188Inactive
Code: LQA7B6G8JG
Classification: IACT
BUTYLATED HYDROXYANISOLEInactive
Code: REK4960K2U
Classification: IACT
SODIUM STARCH GLYCOLATE TYPE A POTATOInactive
Code: 5856J3G2A2
Classification: IACT
STARCH, CORNInactive
Code: O8232NY3SJ
Classification: IACT
LOVASTATINActive
Quantity: 40 mg in 1 1
Code: 9LHU78OQFD
Classification: ACTIB
TALCInactive
Code: 7SEV7J4R1U
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.